• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER MANUFACTURING B.V. STEMMED NONAUGMENTABLE TIBIAL COMPONENT OPTION; KNEE PROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER MANUFACTURING B.V. STEMMED NONAUGMENTABLE TIBIAL COMPONENT OPTION; KNEE PROSTHESIS Back to Search Results
Catalog Number 00-5986-037-01
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Unspecified Infection (1930); Arthrofibrosis (4885)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).D4: complete brand name: stemmed nonaugmentable tibial component option cr/ps/lps size 3 for cemented use only.D10: articular surface size, #item 00596403010, #lot 63054123.Femoral component, #item 00576401451, #lot 62843597.All poly petella, #item 00597206529, #lot 63128479.Stryker simplex cement x2, #item unknown, #lot unknown.Therapy date: implants remains implanted.An investigation of the reported event is in progress.Once the investigation is completed, a supplemental medwatch 3500a will be submitted.
 
Event or Problem Description
It was reported that the patient experienced infection and arthrofibrosis within and unknown timeframe post-initial surgery.Treatment and details of any required interventions are also unknown.Further details have not been provided.Implants remains implanted.Attempts have been made and additional information on the reported event is unavailable at this time.
 
Additional Manufacturer Narrative
Updated: b4,b5,d2,g1,g3,g6,h1,h2,h4,h6.Review of the reported event by a health care professional found: arthrofibrosis is defined as the development of fibrous scar tissue within or surrounding a joint.Arthrofibrosis is a known postoperative procedure related complication that can occur from surgical implantation of new joint replacement as well as from previous injuries or surgical procedures.Scar tissue formation is a normal healing response; however, the buildup of such can result in pain, stiffness, limited range of motion, and difficulty properly ambulating.If excess scar tissue develops, conservative measures such as exercises or physical therapy would be attempted first.If these attempts fail, surgical intervention such as manipulation under anesthesia, arthroscopic arthrolysis, or open arthrotomy would become necessary to remove the fibrous tissue and restore joint function.Product will not be evaluated as it has been determined the event is not related to the device.During the investigation process a review of the sterile certifications were reviewed and found to be conforming with no applicable deviations.Devices were verified to have gone through acceptable sterilization process following iso/aami/astm & eu published guidelines.There are multiple factors that may contribute to an infection that are outside the control of zimmer biomet, such as external factors, i.E.Hospital/surgical environment, provider related risk factors, and/or patient comorbidities/risk factors.As there are no indications of a product or process issues identified affecting implant safety or effectiveness, implanted products are not identified as the source or contributing to the reported infection.The root cause of the reported event was determined to be unrelated to the device.This is a limited investigation, as per process, a review of the device history record and complaint history review will not be completed for limited investigation complaints as the product meets the applicable acceptance criteria.Reported event is not related to a combination of products; therefore, a compatibility review is not applicable.No corrective actions, preventive actions, or field actions resulted after investigation of this event.No product was returned or pictures provided; visual and dimensional evaluations could not be performed.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event or Problem Description
No additional information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STEMMED NONAUGMENTABLE TIBIAL COMPONENT OPTION
Common Device Name
KNEE PROSTHESIS
Manufacturer (Section D)
ZIMMER MANUFACTURING B.V.
turpeaux industrial park
route #1 km 123.4 bldg #1
mercedita PR 00715
Manufacturer (Section G)
ZIMMER MANUFACTURING B.V.
turpeaux industrial park
route #1 km 123.4 bldg #1
mercedita PR 00715
Manufacturer Contact
jennifer rapsavage
56 e. bell dr.
warsaw, IN 46582
5745260384
MDR Report Key23840666
Report Number0002648920-2025-00354
Device Sequence Number13251601
Product Code JWH
UDI-Device Identifier00889024218833
UDI-Public(01)00889024218833(17)250630(10)62795766
Combination Product (Y/N)N
Initial Reporter StateHI
Initial Reporter CountryUS
PMA/510(K) Number
K173057
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2015
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/09/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date06/30/2025
Device Catalogue Number00-5986-037-01
Device Lot Number62795766
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/01/2025
Supplement Date Received by Manufacturer12/31/2025
Initial Report FDA Received Date12/18/2025
Supplement Report FDA Received Date01/13/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/18/2015
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11 NARRATIVE.
Outcome Attributed to Adverse Event Other; Hospitalization;
Patient SexFemale
-
-